Healthcare is the hottest stock sector

The healthcare sector remains a sweet spot for the stock market, ranked the most favored sector on the S&P 500 among Wall Street research firms, Reuters reported.

Overall, the sector saw stocks rise 4.7 percent in 2018, while the benchmark index declined 6.2 percent. Healthcare was one of just two of the S&P 500’s 11 sectors to post positive returns last year.

Heading into 2019, investors remain positive about healthcare, citing an upbeat earnings outlook, among other factors, according to Reuters.

Early reports during the end-of-year earnings season also bode well for the sector. UnitedHealth Group, the nation’s largest health insurer, beat earnings expectations for the fourth quarter of 2018 after reporting its earnings results Tuesday. Its pharmacy benefit manager unit, Optum, reported $27.56 billion in revenue, a 13 percent increase from the year prior.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.